Literature DB >> 22322926

Endothelium/nitric oxide mechanism mediates vasorelaxation and counteracts vasoconstriction induced by low concentration of flavanols.

Annalisa Aggio1, Davide Grassi, Eugenia Onori, Antonio D'Alessandro, Francesco Masedu, Marco Valenti, Claudio Ferri.   

Abstract

PURPOSE: At relatively low concentrations, flavanols induce inconsistent effects on isolated arterial tone, sometimes explained as being due to a structure-activity relationship. The aim of our study was to investigate the effects of two flavanols at different doses on arterial functional state.
METHODS: The effects of two catechins, (-)-epigallocatechin-3-gallate (EGCG) and (-)-epicatechin (EP), on rat-isolated aorta tone were investigated on resting tension and on precontracted preparations, both in the presence and in the absence of endothelium.
RESULTS: At resting tension, endothelium-intact preparations, EGCG and EP (0.01-10 μM), induced a slight concentration-dependent, non-significant contraction. On endothelium-denuded preparations, both EGCG and EP induced a concentration-dependent contraction (significance at 0.1 and 1 μM concentrations of the two compounds, respectively). In phenylephrine (PE) (1 μM) precontracted, endothelium-intact preparations, EGCG and EP (0.01-10 μM), induced a concentration-dependent vasorelaxation, reaching significance at 1 μM concentration of both agonists. On endothelium-denuded preparations, EGCG and EP did not significantly affect PE (0.3 μM)-induced tone. In endothelium-intact precontracted preparations, Nω nitro-L-arginine (L-NNA), a nitric oxide synthase (NOS) activity inhibitor, abolished the vasorelaxant effect of EGCG and EP (0.01-10 μM). At high concentrations, EGCG and EP (100 μM) elicited a marked relaxation. This was significantly larger in the presence than in the absence of endothelium or in the presence of L-NNA.
CONCLUSIONS: Our findings highlight the important role played by an endothelium/NO-mechanism in the regulation of basal tone and in both mediating vasorelaxation and counteracting vasoconstriction induced by low concentrations of flavanols in rat thoracic aorta.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22322926     DOI: 10.1007/s00394-012-0320-x

Source DB:  PubMed          Journal:  Eur J Nutr        ISSN: 1436-6207            Impact factor:   5.614


  39 in total

1.  Short- and long-term black tea consumption reverses endothelial dysfunction in patients with coronary artery disease.

Authors:  S J Duffy; J F Keaney ; M Holbrook; N Gokce; P L Swerdloff; B Frei; J A Vita
Journal:  Circulation       Date:  2001-07-10       Impact factor: 29.690

2.  Vasorelaxant and antioxidant activity of flavonols and flavones: structure-activity relationships.

Authors:  Owen L Woodman; William F Meeker; Mirna Boujaoude
Journal:  J Cardiovasc Pharmacol       Date:  2005-09       Impact factor: 3.105

3.  Study of the mechanisms involved in the vasorelaxation induced by (-)-epigallocatechin-3-gallate in rat aorta.

Authors:  Ezequiel Alvarez; Manuel Campos-Toimil; Hélène Justiniano-Basaran; Claire Lugnier; Francisco Orallo
Journal:  Br J Pharmacol       Date:  2006-02       Impact factor: 8.739

4.  Involvement of endothelium/nitric oxide in vasorelaxation induced by purified green tea (-)epicatechin.

Authors:  Y Huang; N W Chan; C W Lau; X Q Yao; F L Chan; Z Y Chen
Journal:  Biochim Biophys Acta       Date:  1999-04-19

5.  Depression of contractile responses in rat aorta by spontaneously released endothelium-derived relaxing factor.

Authors:  W Martin; R F Furchgott; G M Villani; D Jothianandan
Journal:  J Pharmacol Exp Ther       Date:  1986-05       Impact factor: 4.030

6.  (-)-Epigallocatechin-3-gallate induces contraction of the rat aorta by a calcium influx-dependent mechanism.

Authors:  Ezequiel Alvarez-Castro; Manuel Campos-Toimil; Francisco Orallo
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-04-09       Impact factor: 3.000

Review 7.  Green tea (Camellia sinensis) catechins and vascular function.

Authors:  Rosalind J Moore; Kim G Jackson; Anne M Minihane
Journal:  Br J Nutr       Date:  2009-12       Impact factor: 3.718

8.  Acute EGCG supplementation reverses endothelial dysfunction in patients with coronary artery disease.

Authors:  Michael E Widlansky; Naomi M Hamburg; Elad Anter; Monika Holbrook; David F Kahn; James G Elliott; John F Keaney; Joseph A Vita
Journal:  J Am Coll Nutr       Date:  2007-04       Impact factor: 3.169

9.  Blood pressure is reduced and insulin sensitivity increased in glucose-intolerant, hypertensive subjects after 15 days of consuming high-polyphenol dark chocolate.

Authors:  Davide Grassi; Giovambattista Desideri; Stefano Necozione; Cristina Lippi; Raffaele Casale; Giuliana Properzi; Jeffrey B Blumberg; Claudio Ferri
Journal:  J Nutr       Date:  2008-09       Impact factor: 4.798

10.  A constituent of green tea, epigallocatechin-3-gallate, activates endothelial nitric oxide synthase by a phosphatidylinositol-3-OH-kinase-, cAMP-dependent protein kinase-, and Akt-dependent pathway and leads to endothelial-dependent vasorelaxation.

Authors:  Mario Lorenz; Silja Wessler; Elena Follmann; Wanda Michaelis; Thomas Düsterhöft; Gert Baumann; Karl Stangl; Verena Stangl
Journal:  J Biol Chem       Date:  2003-11-24       Impact factor: 5.157

View more
  18 in total

1.  Epigallocatechin gallate (EGCG) alleviates vascular dysfunction in angiotensin II-infused hypertensive mice by modulating oxidative stress and eNOS.

Authors:  Nurul Aiza Mohd Sabri; Siew-Keah Lee; Dharmani Devi Murugan; Wei Chih Ling
Journal:  Sci Rep       Date:  2022-10-21       Impact factor: 4.996

Review 2.  Mechanisms of body weight reduction and metabolic syndrome alleviation by tea.

Authors:  Chung S Yang; Jinsong Zhang; Le Zhang; Jinbao Huang; Yijun Wang
Journal:  Mol Nutr Food Res       Date:  2015-12-09       Impact factor: 5.914

3.  Epicatechin's cardiovascular protective effects are mediated via opioid receptors and nitric oxide.

Authors:  Kirsty MacRae; Kylie Connolly; Rebecca Vella; Andrew Fenning
Journal:  Eur J Nutr       Date:  2018-05-10       Impact factor: 5.614

4.  Endothelial NO Production Is Mandatory for Epigallocatechin-3-Gallate-induced Vasodilation: Results From eNOS Knockout (eNOS-/-) Mice.

Authors:  Mario Lorenz; Laura Klinkner; Gert Baumann; Karl Stangl; Verena Stangl
Journal:  J Cardiovasc Pharmacol       Date:  2015-06       Impact factor: 3.105

Review 5.  Vascular and metabolic actions of the green tea polyphenol epigallocatechin gallate.

Authors:  Michelle A Keske; Huei L H Ng; Dino Premilovac; Stephen Rattigan; Jeong-A Kim; Kashif Munir; Peixin Yang; Michael J Quon
Journal:  Curr Med Chem       Date:  2015       Impact factor: 4.530

6.  (-)-Epicatechin Prevents Blood Pressure Increase and Reduces Locomotor Hyperactivity in Young Spontaneously Hypertensive Rats.

Authors:  M Kluknavsky; P Balis; A Puzserova; J Radosinska; A Berenyiova; M Drobna; S Lukac; J Muchova; I Bernatova
Journal:  Oxid Med Cell Longev       Date:  2016-11-03       Impact factor: 6.543

7.  Motor phenotype is not associated with vascular dysfunction in symptomatic Huntington's disease transgenic R6/2 (160 CAG) mice.

Authors:  A Di Pardo; A Carrizzo; A Damato; S Castaldo; E Amico; L Capocci; M Ambrosio; F Pompeo; C De Sanctis; C C Spinelli; A A Puca; P Remondelli; V Maglione; C Vecchione
Journal:  Sci Rep       Date:  2017-02-17       Impact factor: 4.379

8.  Tea-induced improvement of endothelial function in humans: No role for epigallocatechin gallate (EGCG).

Authors:  Mario Lorenz; Franziska Rauhut; Christine Hofer; Stefanie Gwosc; Eda Müller; Damaris Praeger; Benno F Zimmermann; Klaus-Dieter Wernecke; Gert Baumann; Karl Stangl; Verena Stangl
Journal:  Sci Rep       Date:  2017-05-23       Impact factor: 4.379

Review 9.  Vasodilator compounds derived from plants and their mechanisms of action.

Authors:  Francisco J Luna-Vázquez; César Ibarra-Alvarado; Alejandra Rojas-Molina; Isela Rojas-Molina; Miguel Angel Zavala-Sánchez
Journal:  Molecules       Date:  2013-05-17       Impact factor: 4.411

10.  Phenolics from Garcinia mangostana alleviate exaggerated vasoconstriction in metabolic syndrome through direct vasodilatation and nitric oxide generation.

Authors:  Hossam M Abdallah; Hany M El-Bassossy; Gamal A Mohamed; Ali M El-Halawany; Khalid Z Alshali; Zainy M Banjar
Journal:  BMC Complement Altern Med       Date:  2016-09-13       Impact factor: 3.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.